David J Apple Laboratory

    clinical research news,

    Safety in IOL exchange

    Timur Yildirim - Author photo
    Timur Yildirim Follow Paper
    Published: Jun 30, 2025 · Updated: Mar 08, 2026 · 2 mins read
    Safety in IOL exchange - Featured image

    Heidelberg 30 June 2025. We recently studied cases of IOL exchange and in April this year published our results in Scientific Reports, the peer-reviewed open-access journal published by Nature Portfolio:

    Henningsen N, Khoramnia R, Auffarth GU, Köppe MK, Łabuz G, Yildirim TM. Visual and refractive outcome, higher order aberrations and complications following intraocular lens exchange in eyes without comorbidities. Sci Rep. 2025 Apr 23;15(1):14202. doi: 10.1038/s41598-025-98931-y. PMID: 40269218; PMCID: PMC12019354.

    Background

    In cases with severe IOL-related complications, IOL exchange is often the best treatment option. There is limited published data on the impact of this procedure on refractive outcomes and intra- and postoperative complications, particularly in patients with otherwise healthy eyes. 

    What did we do?

    We investigated the refractive outcome of IOL exchange surgery, including corneal aberrations, and assessed the influence of different IOL characteristics on intraoperative and postoperative complications. 

    Our methods

    We conducted a prospective clinical study that included 35 eyes with homogeneous IOL calcification and no other ocular pathologies. We measured the eyes’ corrected distance visual acuity (CDVA) using the Pentacam AXL Wave (Oculus Optikgeräte GmbH, Wetzlar, Germany), comparing target refraction to the postoperative spherical equivalent. Corneal topography and lower- and higher-order aberrations were assessed preoperatively and 3 months postoperatively. 

    a. before IOL exchange and b after IOL exchange

    • Photo montages of a. before IOL exchange and b after IOL exchange

    We also recorded intraoperative and postoperative complications and compared these complications between different IOL characteristics. 

    Our results

    The secondary IOL in 53% of cases, was a retropupillary iris-fixated Artisan Aphakia (Ophtec BV, Groningen, Netherlands), 37% had a sulcus-fixated AR40e (Johnson & Johnson Vision, Irvine, USA), and 10% received a capsular bag IOL. The CDVA improved from 0.16 ± 0.14 to 0.07 ± 0.14 logMAR (p = 0.04). In most cases, the target refraction was within ± 1.0 D (Artisan: 71%, AR40e: 90%, Capsular: 100%). IOL exchange did not induce relevant change in corneal aberrations. Anterior (81%) and posterior (78%) vitrectomy were performed in most cases.

    Corneal lower and higher order aberrations (LOA/ HOA), horizontal and vertical astigmatism (Z2 2, Z2 -2), coma (Z3 1, Z3 -1), trefoil (Z3 3, Z3 -3) and spherical aberrations (Z4 0) pre- and post-operative for the 3 mm and 5 mm zone. Mean values in Diopter (D) with standard deviation.

    • Corneal aberrations at 3mm and 5mm The graphs show Corneal lower and higher order aberrations (LOA/ HOA), horizontal and vertical astigmatism (Z2 2, Z2 -2), coma (Z3 1, Z3 -1), trefoil (Z3 3, Z3 -3) and spherical aberrations (Z4 0) pre- and post-operative for the 3 mm and 5 mm zone. Mean values in Diopter (D) with standard deviation.

    We noted that the haptic design of the primary IOL did not affect intra- or postoperative complications. 

    Our Conclusions

    Although exchanging an IOL involves greater surgery compared to the initial IOL implantation, visual and refractive outcomes are generally good, and the exchange does not cause a significant change in aberrations. Intra- and postoperative complications are mostly mild and resolve without sequelae.

    Our paper is open access, and the link to view it is:

    https://www.nature.com/articles/s41598-025-98931-y

    Cite This Article
    Timur Yildirim. (2025, June 30). Safety in IOL exchange. David J Apple Laboratory. https://djapplelab.com/timur/
    Timur Yildirim. "Safety in IOL exchange." David J Apple Laboratory, 30 Jun. 2025, https://djapplelab.com/timur/.
    Timur Yildirim. "Safety in IOL exchange." David J Apple Laboratory. June 30, 2025. https://djapplelab.com/timur/.
    @article{safety-in-iol-exchange, author = {Timur Yildirim}, title = {Safety in IOL exchange}, journal = {David J Apple Laboratory}, year = }, month = }, url = /timur/}, note = {Accessed: 2026-03-08} }
    Timur Yildirim - Author photo
    Written by Timur Yildirim Follow Paper
    PD Dr. med. Timur Yildirim, MD, FEBO, is an Ophthalmologist in the Cataract and Refractive Surgery faculty at the Heidelberg University Eye Clinic; and he is active in ophthalmic laboratory research at the David J Apple®️ Center for Vision Research.